[Home ]      
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 5, Number 3 (Int J Mol Cell Med 2016) ::
Back to browse issues page Int J Mol Cell Med 2016, 5(3): 125-133
Down Syndrome: Current Status, Challenges and Future Perspectives
Mohammad Kazemi1, Mansoor Salehi *2, Majid Kheirolahi3
1- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
2- Medical Genetic Center of Genome, Isfahan, Iran., Medical Genetic Center of Genome, Isfahan, Iran. , m_salehi@med.mui.ac.ir
3- Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran., Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract:   (640 Views)

Down syndrome (DS) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. It is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. Although the syndrome had been described thousands of years before, it was named after John Langdon Down who described its clinical description in 1866. Scientists have identified candidate genes that are involved in the formation of specific DS features. These advances in turn may help to develop targeted therapy for persons with trisomy 21. Screening for DS is an important part of routine prenatal care. Until recently, noninvasive screening for aneuploidy depends on the measurement of maternal serum analytes and ultrasonography. More recent progress has resulted in the development of noninvasive prenatal screening (NIPS) test using cell-free fetal DNA sequences isolated from a maternal blood sample. A review on those achievements is discussed.

Keywords: Down syndrome, trisomy 21, prenatal diagnosis, chromosome abnormality, cell-free fetal DNA (cffDNA), noninvasive prenatal screening (NIPS)
Full-Text [PDF 146 kb]   (971 Downloads)    
Type of Study: Review | Subject: Genetics & Disease
Received: 2016/05/10 | Accepted: 2016/07/2 | Published: 2016/08/10
Add your comments about this article
Your username or email:

Write the security code in the box >



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazemi M, Salehi M, Kheirolahi M. Down Syndrome: Current Status, Challenges and Future Perspectives. Int J Mol Cell Med. 2016; 5 (3) :125-133
URL: http://ijmcmed.org/article-1-518-en.html
Back to browse issues page Volume 5, Number 3 (Int J Mol Cell Med 2016)
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 778 queries by AWT YEKTAWEB 3220